Article PDF
Avoid common mistakes on your manuscript.
References
Stamenkovic I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403–1410, 1989
Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019–1023, 1990
Mallett S, Barclay AN: A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol Today 12:220–223, 1991
Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421–427, 1992
Clark EA: CD40: A cytokine receptor in search of a ligand. Tissue Antigens 36:33–36, 1990
Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F: Long term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70–72, 1991
Jabara HH, Fu SM, Geha RS, Vercelli D: CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and interleukin-6 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 172:1861–1864, 1990
Rousset F, Garcia E, Banchereau J: Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 173:705–710, 1991
Zhang K, Clark EA, Saxon A: CD40 stimulation provides and IFN-γ-independent and IL-4-dependent differentiation directly to human B cells for IgE production. J Immunol 146:1836–1842, 1991
Gascan H, Gauchat J-F, Aversa G, van Vlasselaer P, de Vries JE: Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signalling pathways. J Immunol 147:8–13, 1991
Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890–1893, 1992
Shapira SK, Vercelli D, Jabara HH, Fu SM, Geha RS: Molecular analysis of the induction of immunoglobulin E synthesis in human B cell by interleukin 4 and engagement of CD40 antigen. J Exp Med 175:289–292, 1992
Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennon ICM: Mechanism of antigen-driven selection in germinal centres. Nature (London) 342:929–931, 1989
Liu YJ, Cairns JA, Holder MJ, Abbot SD, Jansen KU, Bonnefoy JY, Gordon J, Mac Lennan IC: Recombinant 25-kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 21:1107–1114, 1991
Liu YJ, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, Mac Lennan IC: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21:1905–1910, 1991
Galy AH, Spits H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 149:775–782, 1992
Gordon J, Millsum MJ, Guy GR, Ledbetter JA: Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. J Immunol 140:1425, 1988
Barrett TB, Shu G, Clark EA: CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J Immunol 146:1722, 1991
Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC: Recombinant human CD40 ligand stimulates B cell proliferation and Immunoglobulin E secretion. J Exp Med 176:1543–1550, 1992
Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA: Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 22:3191–3194, 1992
Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny ND, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell costimulatory activity. EMBO J 11:4313–4321, 1992
Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Spriggs MK: Molecular and biological characterization of a murine ligand for CD40. Nature (London) 357:80–82, 1992
Farrah T, Smith CA: Emerging cytokine family. Nature (London) 358:26, 1992
Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow WC, Belmont J, Spriggs MK: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990–993, 1993
Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD: The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291–300, 1993
Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA: Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper IgM. Nature (London) 361:539–541, 1993
DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G: CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (London) 361:541–543, 1993
Geha RS, Hyslop N, Alami S, Farah F, Schneeberger EE, Rosen FS: Hyper immunoglobulin M immunodeficiency. (Dysgammaglobulinemia). Presence of immunoglobulin M-secreting plasmacytoid cells in peripheral blood and failure of immunoglobulin M-immunoglobulin G switch in B-cell differentiation. J Clin Invest 64:385–391, 1979
Noelle RJ, McCann J, Marshall L, Bartlett WC: Cognate interactions between helper B cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells. J Immunol 143:1807, 1989
Noelle RJ, Snow EC: T helper cell-dependent B cell activation. FASEB J 5:2770–2706, 1991
Noelle RJ, Daum J, Bartlett WC, McCann J, Shepherd DM: Cognate interactions between helper T cells and B cells. V. Reconstitution of helper T cell function using purified plasma membranes from activated Th1 and Th2 helper T cells and lymphokines. J Immunol 146:1118–1124, 1990
Brian AA: Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells. Proc Natl Acad Sci USA 85:564–568, 1988
Sekita K, Straub C, Hoessli D, Zubler RH: B cell-stimulating activity of lymphoid cell membrane fractions. Eur J Immunol 18:1405–1410, 1988
Hodgkin PD, Yamashita LC, Coffman RL, Kehry MR: Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J Immunol 145:2025–2034, 1990
Fanslow WC, Anderson D, Grabstein KH, Clark EA, Cosman D, Armitage RJ: Soluble forms of CD40 inhibit biological responses of human B cells. J Immunol 149:655–660, 1992
McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI, Copeland NG, Huebner K, Croce CM, Cannizzarro LA, Benjamin D, Dower SK, Spriggs MK, Sims JE: A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10:2821–2832, 1991
Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC: Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 150:3671–3680, 1993
Andersson J, Schreier MH, Melchers F: T-cell-dependent B-cell stimulation isH-2 restricted and antigen dependent only at the resting B-cell level. Proc Natl Acad Sci USA 77:1612–1616, 1980
Peitsch MC, Jongeneel CV: A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int Immunol 5:233–238, 1993
Armitage RJ, Tough TW, Macduff BM, Fanslow WC, Spriggs MK, Ramsdell F, Alderson MR: CD40 ligand is a T-cell growth factor. Eur J Immunol (in press), 1993
Copeland NG, Jenkins NA: Development and applications of a molecular genetic linkage map of the mouse genome. Trends Genet 7:113–118, 1991
Mensink EJ, Thompson A, Sandkuyl LA, Kraakman ME, Schot JD, Espanol T, Schuurman RK: X-linked immunodeficiency with hyperimmunoglobulinemia M appears to be linked to the DXS42 restriction fragment length polymorphism locus. Hum Genet 76:96–99, 1987
Padayachee M, Feighery C, Finn A, McKeown C, Levinsky RJ, Kinnon C, Malcolm S: Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics 14:551–553, 1992
Rosen FS, Kevy SV, Merler E, Janeway CA, Gitlin D: Recurrent bacterial infections and dysgammaglobulinemia: Deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Pediatrics 28:182–195, 1961
Notarangelo LD, Duse M, Ugazio AG: Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 3:101–121, 1992
Conley ME: Molecular approaches to analysis of X-linked immunodeficiencies. Annu Rev Immunol 10:215–238, 1992
Mayer L, Kwan SP, Thompson C, Ko HS, Chiorazzi N, Waldmann T, Rosen F: Evidence for a defect in “switch” T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med 314:409–413, 1986
Levitt D, Haber P, Rich K, Cooper MD: Hyper IgM immunodeficiency. A primary dysfunction of B lymphocyte isotype switching. J Clin Invest 72:1650–1657, 1983
Hendriks RW, Kraakman ME, Craig IW, Espanol T, Schuurman RK: Evidence that in X-linked immunodeficiency with hyperimmunoglobulinemia M the intrinsic immunoglobulin heavy chain class switch mechanism is intact. Eur J Immunol 20:2603–2608, 1990
Fanslow WC, Clifford KY, Seaman M, Alderson MR, Spriggs MK, Armitage RJ, Ramsdell F: Recombinant CD40-ligand exerts potent biological effects on T cells. J Immunol (in press) 1993
Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK: CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178:669, 1993
Allen RC, Spriggs MK, Belmont JW: Dinucleotide repeat polymorphism in the human CD40 ligand gene. Hum Mol Genet 2:828, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spriggs, M.K., Fanslow, W.C., Armitage, R.J. et al. The biology of the human ligand for CD40. J Clin Immunol 13, 373–380 (1993). https://doi.org/10.1007/BF00920012
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00920012